Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amantadine in Chronic Hepatitis C (CIRA)
NCT00146016Phase 3Completed
- Start
- Feb 2000
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of amantadine in hepatitis C (HCV). Started Feb 2000; status: completed.
02
Drugs
amantadine
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT00146016.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00146016.